China Biologic Products, Inc. 4
4 · China Biologic Products, Inc. · Filed Oct 21, 2015
Insider Transaction Report
Form 4
Gao David
Director
Transactions
- Sale
Common Stock
2015-10-19$105.03/sh−200$21,005→ 616,800 total - Sale
Common Stock
2015-10-20$105.00/sh−258$27,090→ 616,542 total
Footnotes (2)
- [F1]Represents 458 shares of common stock sold through a trading plan (the "10b5-1 Plan") adopted by the Reporting Person on September 14, 2015 that complies with the requirements of Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended. The Reporting Person intends to use the proceeds from the sales effected under the 10b5-1 Plan to pay income tax due in connection with the scheduled vesting of certain restricted stock held by the Reporting Person and the exercise of certain stock options held by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $105.020 to $105.030, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 2.